Skoči na glavni sadržaj

Pregledni rad

https://doi.org/10.5772/61114

Addressing Barriers to the Development and Adoption of Rapid Diagnostic Tests in Global Health

Eric Miller ; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, USA
Hadley D. Sikes ; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, USA


Puni tekst: engleski pdf 971 Kb

str. 2-6

preuzimanja: 732

citiraj


Sažetak

Immunochromatographic rapid diagnostic tests (RDTs) have demonstrated significant potential for use as point-of-care diagnostic tests in resource-limited settings. Most notably, RDTs for malaria have reached an unparalleled level of technological maturity and market penetration, and are now considered an important complement to standard microscopic methods of malaria diagnosis. However, the technical development of RDTs for other infectious diseases, and their uptake within the global health community as a core diagnostic modality, has been hindered by a number of extant challenges. These range from technical and biological issues, such as the need for better affinity agents and biomarkers of disease, to social, infrastructural, regulatory and economic barriers, which have all served to slow their adoption and diminish their impact. In order for the immunochromatographic RDT format to be successfully adapted to other disease targets, to see widespread distribution, and to improve clinical outcomes for patients on a global scale, these challenges must be identified and addressed, and the global health community must be engaged in championing the broader use of RDTs.

Ključne riječi

Rapid diagnostic tests; infectious disease; immunochromatography; point-of-care; global health

Hrčak ID:

157658

URI

https://hrcak.srce.hr/157658

Datum izdavanja:

1.1.2015.

Posjeta: 1.830 *